Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.
No spam, ever. Unsubscribe anytime.
Substance Profile
Escaline (3,5-dimethoxy-4-ethoxyphenethylamine) is a synthetic mescaline analog in which the 4-methoxy group is replaced with an ethoxy group. First described in 1971 and later characterized by Alexander Shulgin in PiHKAL, escaline produces mescaline-like effects with visual phenomena and empathogenic qualities at a somewhat shorter duration of 6-8 hours. Potency is comparable to mescaline, requiring oral doses in the 40-200 mg range.
No subjective effects data available yet.
No linked studies yet.